Alice Rathjen is one of the early pioneers in computational biology and genomic spatial analysis.
With over two decades of experience as a genomics entrepreneur, Alice has launched groundbreaking platforms in the genetic field, including Dominga, the first direct-to-consumer genetic testing service in 2000, and DNA Guide, the first genome browser for mobile platforms in 2009. Her presentations on precision medicine have surpassed 55,000 views. You can find more details about her work in the ESRI book on Women in GIS or listen to her recent podcast with Indu Subaiya on HIMSS.Alice brings to DNA Compass her passion for patient-centered data and building federated genomics infrastructure to deliver consented genomes at scale. Follow her on Twitter at @dnatimes.
Kevin Noble is recognized for his ability to develop cross-functional teams committed to identifying original solutions to challenging problems. With a deep passion for creativity, integrity, and collaboration, he has worked to create cultures and environments where people want to be a part of every day.
With successful experience leading key brands, managing organizational change, and accelerating innovation initiatives, Kevin has driven business growth, better experiences, and exceptional results.
His unique approach is focused on fostering a culture of constant innovation aligned with DNA Compass’s strategic goals.
Xavier Thomas is a customer-centric serial entrepreneur with a proven track record of scaling revenue in advertising technology and marketing services. As an inventor of patented, validated bioinformatics solutions, Xavier has made significant contributions to the genomics and healthcare industries.
He is a passionate speaker on topics such as user experience, lean startup methodology, and ethical frameworks for genomics at scale. Having co-founded three companies and serving as an active advisor to numerous startups and scaleups, Xavier is driven by a mission to unleash the potential of linked data to benefit entire populations. His goal is to democratize access to genetic insights, making them available across industries, clinicians, and consumers.